Clinical Pharmacokinetics and Summary of Efficacy and Tolerability of Atazanavir
作者： Clotilde Le Tiec , Aur??lie Barrail , C??cile Goujard , Anne-Marie Taburet
DOI: 10.2165/00003088-200544100-00003
关键词:
摘要: The efficacy of HIV-1 protease inhibitors (PIs) as part highly active antiretroviral therapy is now well established and has provided benefits to many patients with HIV infection. Atazanavir a new azapeptide PI compound that was recently approved in the US Europe. recommended combination other agents for treatment
springer.com
unirioja.es
sci-hub.se 参考文章(63)
Bartlett Jg, Major controversies in the DHHS guidelines for use of antiretroviral agents in HIV-infected adults. Department of Health and Human Services. The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service. ,vol. 10, ,(1998)
Richard B Kim, Drug transporters in HIV Therapy. Topics in HIV medicine : a publication of the International AIDS Society, USA. ,vol. 11, pp. 136- ,(2003)
Mark S. Sulkowski, Drug-Induced Liver Injury Associated with Antiretroviral Therapy that Includes HIV-1 Protease Inhibitors Clinical Infectious Diseases. ,vol. 38, ,(2004) , 10.1086/381444
Sharon Safrin, Carl Grunfeld, Fat distribution and metabolic changes in patients with HIV infection AIDS. ,vol. 13, pp. 2493- 2505 ,(1999) , 10.1097/00002030-199912240-00002
Marta Boffito, Michael Kurowski, Guido Kruse, Andrew Hill, Andrew A Benzie, Mark R Nelson, Graeme J Moyle, Brian G Gazzard, Anton L Pozniak, Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen. AIDS. ,vol. 18, pp. 1291- 1297 ,(2004) , 10.1097/00002030-200406180-00007
Sabine Paci‐Bonaventure, Ali Hafi, Isabelle Vincent, Yann Quertainmont, Cécile Goujard, Bernard Charpentier, Anne‐Marie Taburet, Lack of removal of nelfinavir during a haemodialysis session in an HIV‐1 infected patient with hepatic and renal insufficiency Nephrology Dialysis Transplantation. ,vol. 16, pp. 642- 643 ,(2001) , 10.1093/NDT/16.3.642
Robin Wood, Praphan Phanuphak, Pedro Cahn, Vadim Pokrovskiy, Willy Rozenbaum, Giuseppe Pantaleo, Michael Sension, Robert Murphy, Marco Mancini, Thomas Kelleher, Michael Giordano, Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir. Journal of Acquired Immune Deficiency Syndromes. ,vol. 36, pp. 684- 692 ,(2004) , 10.1097/00126334-200406010-00005
S. Colombo, A. Beguin, A. Telenti, J. Biollaz, T. Buclin, B. Rochat, L.A. Decosterd, Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry. Journal of Chromatography B. ,vol. 819, pp. 259- 276 ,(2005) , 10.1016/J.JCHROMB.2005.02.010
Anne‐Marie Taburet, Gilles Raguin, Clotilde Le Tiec, Cécile Droz, Aurélie Barrail, Isabelle Vincent, Laurence Morand‐Joubert, Geneviève Chêne, François Clavel, Pierre‐Marie Girard, Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus. Clinical Pharmacology & Therapeutics. ,vol. 75, pp. 310- 323 ,(2004) , 10.1016/J.CLPT.2003.12.013
Patrick F. Smith, Robert DiCenzo, Gene D. Morse, Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors. Clinical Pharmacokinectics. ,vol. 40, pp. 893- 905 ,(2001) , 10.2165/00003088-200140120-00002